Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.

Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.

Sci Rep. 2017 Oct 06;7(1):12782

Authors: Shiromizu T, Kume H, Ishida M, Adachi J, Kano M, Matsubara H, Tomonaga T

Abstract
At the moment, there is no sensitive clinical test for detecting early-stage colorectal cancer (CRC). Target proteomics has enabled high-throughput verification of hundreds of biomarker candidate proteins. Using this technology, we verified 725 previously reported CRC biomarker candidate proteins that are functionally correlated with CRC in extracellular vesicles (EVs) from patients. Of these, 356 proteins were quantified, and 34 peptides (22 proteins) showed significant differences in the serum EVs between healthy controls and CRC patients of two independent cohorts (n = 77 and 84). These peptides were evaluated as single or multiple markers, and four single peptides in annexin family proteins and eight combinations of peptides showed area under the curve > 0.9 for discriminating between healthy controls and CRC patients. The sensitivities of annexins A3, A4, and A11 peptides for detecting early-stage CRC greatly exceed those of carcinoembryonic antigen. These peptides are promising biomarkers for early detection of CRC.

PMID: 28986585 [PubMed - in process]

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2gm9Yeh
via IFTTT